Granules India Faces FDA Warning Letter for Gagillapur Facility, Operations Continue

Unknown Apr 02, 2026 950 Views

Granules India Ltd has announced that it received a Warning Letter from the US Food and Drug Administration (FDA) on February 26, 2025, regarding its Gagillapur facility. The letter follows an inspection conducted in August 2024, which resulted in an "Official Action Indicated" (OAI) cl...